These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24588662)

  • 1. A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.
    Jeng CJ; Chuang L; Shen J
    Expert Opin Pharmacother; 2014 Apr; 15(6):767-73. PubMed ID: 24588662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of endometriosis-related pain.
    Vercellini P; Buggio L; Frattaruolo MP; Borghi A; Dridi D; Somigliana E
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():68-91. PubMed ID: 29530425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of endometriosis: a systematic review.
    Schroder AK; Diedrich K; Ludwig M
    IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
    Surrey ES; Voigt B; Fournet N; Judd HL
    Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.
    Sadler Gallagher J; Feldman HA; Stokes NA; Laufer MR; Hornstein MD; Gordon CM; DiVasta AD
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):215-222. PubMed ID: 26927501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the medical treatment of endometriosis.
    Minjarez DA; Schlaff WD
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):641-51. PubMed ID: 10958009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines].
    Sauvan M; Chabbert-Buffet N; Geoffron S; Legendre G; Wattier JM; Fernandez H
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):264-266. PubMed ID: 29519595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms associated with gonadotropin-releasing hormone agonists.
    Warnock JK; Bundren JC; Morris DW
    Depress Anxiety; 1998; 7(4):171-7. PubMed ID: 9706454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group.
    Fertil Steril; 1996 Dec; 66(6):911-9. PubMed ID: 8941054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
    Surrey ES; Hornstein MD
    Obstet Gynecol; 2002 May; 99(5 Pt 1):709-19. PubMed ID: 11978277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern combined oral contraceptives for pain associated with endometriosis.
    Moore J; Kennedy S; Prentice A
    Cochrane Database Syst Rev; 2000; (2):CD001019. PubMed ID: 10796731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.